Cargando…
Promoter Hypomethylation of miR-124 Gene Is Associated With Major Depressive Disorder
Based on our previous studies and other evidence, miR-124 is an important biomarker and therapeutic target for major depressive disorder (MDD). The aim of this study was to clarify the role of miR-124 methylation in MDD and antidepressant effects from the perspective of epigenetics. MethylTarget™ wa...
Autores principales: | Zeng, Duan, He, Shen, Zhao, Nan, Hu, Manji, Gao, Jie, Yu, Yimin, Huang, Jingjing, Shen, Yifeng, Li, Huafang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724533/ https://www.ncbi.nlm.nih.gov/pubmed/34992522 http://dx.doi.org/10.3389/fnmol.2021.771103 |
Ejemplares similares
-
Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response
por: Zeng, Duan, et al.
Publicado: (2018) -
Optimized miR-124 reporters uncover differences in miR-124 expression among neuronal populations in vitro
por: Lepolard, Catherine, et al.
Publicado: (2023) -
Co-Expression Network Analysis Revealed That the ATP5G1 Gene Is Associated With Major Depressive Disorder
por: Zeng, Duan, et al.
Publicado: (2019) -
miR194 hypomethylation regulates coronary artery disease pathogenesis
por: Duan, Lian, et al.
Publicado: (2022) -
The efficacy and safety of Anyu Peibo Capsule in the treatment of patients with major depressive disorder in China: study protocol for a randomized placebo-controlled trial
por: Huang, Jingjing, et al.
Publicado: (2021)